News
Adam Parker, Trivariate Research CEO, said in a recent interview with CNBC that it’s “hard” to be bullish in this market ...
We recently published a list of Jim Cramer’s Thoughts on These 5 Stocks. In this article, we are going to take a look at ...
Insider Monkey on MSN13d
Johnson & Johnson (JNJ): Stuck in a Range but Ready to Break Out if Legal Clouds Clear – Jim Cramer Weighs InREAD ALSO: Jim Cramer Discussed These 12 Stocks and 10 Stocks on Jim ... we get an update on the firm’s legal strategy ...
Mad Money host Jim Cramer cautioned viewers about what may lie ahead once the 90-day pause on new tariffs comes to an end.
Despite some optimism in the market after President Donald Trump’s indication of possible talks with China, Wall Street ...
READ ALSO: Jim Cramer’s Game Plan for Next Week ... The company is involved in treatments for heart disease, infectious diseases, cancer, immune disorders, and vaccines. Two weeks ago ...
On Thursday, Jim Cramer, the host of Mad Money ... Highlighting the current focus on preventative medicine and the Cancer Moonshot, a caller asked his thoughts on GRAIL, Inc. (NASDAQ:GRAL ...
The company is involved in treatments for heart disease, infectious diseases, cancer, immune disorders, and vaccines. Two weeks ago, discussing the company, Cramer stated: “Well, let me tell you ...
On Wednesday, Jim Cramer, the host of Mad Money ... produces a variety of medicines across several health areas. Its work includes cancer treatments, vaccines, and products for animal health.
On Wednesday, Jim Cramer, the host of Mad Money ... including treatments for diabetes, cancer, autoimmune diseases, pain, and migraines. Parnassus Investments stated the following regarding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results